Dr. Saveen Semage re-appointed as CEO of NMRA
The Ministry of Health announced the re-appointment of Dr. Saveen Semage as the new Chief Executive Officer (CEO) of the National Medicines Regulatory Authority (NMRA) today (January 09).
Dr. Saveen Semage previously served as the CEO of the NMRA from November 2021 until May 2022, before he resigned from the position.
In May 2022, Dr. Saveen Semage announced his resignation as the CEO of NMRA on social media, blaming the move by Ravi Kumudesh, President of the College of Medical Laboratory Science, over allegations leveled at NMRA over the drug shortage at that time.
The new appointment was made by Health Minister Dr. Ramesh Pathirana, following a selection process from among applications submitted for the vacant position.
Latest Headlines in Sri Lanka
- Grade 5 scholarship exam today at 2,849 centres across Sri Lanka September 15, 2024
- Alex Marshall warns of corruption threats in local T20 leagues September 14, 2024
- IMF to resume Sri Lanka program discussions following Presidential Election September 14, 2024
- Sri Lanka to lift motor vehicle import ban in phases starting October 2024 September 14, 2024
- Sri Lanka government proposes personal income tax relief September 13, 2024